BRPI9816233B8 - processo de preparação de insulinas ou de um derivado de insulina - Google Patents

processo de preparação de insulinas ou de um derivado de insulina

Info

Publication number
BRPI9816233B8
BRPI9816233B8 BRPI9816233A BR9816233A BRPI9816233B8 BR PI9816233 B8 BRPI9816233 B8 BR PI9816233B8 BR PI9816233 A BRPI9816233 A BR PI9816233A BR 9816233 A BR9816233 A BR 9816233A BR PI9816233 B8 BRPI9816233 B8 BR PI9816233B8
Authority
BR
Brazil
Prior art keywords
insulins
preparing
insulin
insulin derivative
obtaining
Prior art date
Application number
BRPI9816233A
Other languages
English (en)
Other versions
BRPI9816233B1 (pt
Inventor
Rubroeder Franz-Josef
Keller Reinhold
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of BRPI9816233B1 publication Critical patent/BRPI9816233B1/pt
Publication of BRPI9816233B8 publication Critical patent/BRPI9816233B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

processo de preparação de insulinas ou de um derivado de insulina. processo aperfeiçoado para obtenção de precursores de insulina tendo ponte de cistina corretamente ligadas. a presente invenção refere-se a um processo aperfeiçoado para obtenção de um precursor de insulina ou derivados de insulina tendo ponte de cistina corretamente ligadas na presença de cisteina ou cloridrato de cistema e de um auxiliar caotrópico.
BRPI9816233A 1997-08-18 1998-08-17 processo de preparação de insulinas ou de um derivado de insulina BRPI9816233B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
BR9803755-2A BR9803755A (pt) 1997-08-18 1998-08-17 Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.

Publications (2)

Publication Number Publication Date
BRPI9816233B1 BRPI9816233B1 (pt) 2016-09-27
BRPI9816233B8 true BRPI9816233B8 (pt) 2021-05-25

Family

ID=7839275

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI9816233A BRPI9816233B8 (pt) 1997-08-18 1998-08-17 processo de preparação de insulinas ou de um derivado de insulina
BR9803755-2A BR9803755A (pt) 1997-08-18 1998-08-17 Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR9803755-2A BR9803755A (pt) 1997-08-18 1998-08-17 Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.

Country Status (20)

Country Link
US (3) US5986048A (pt)
EP (2) EP0906918B1 (pt)
JP (1) JP4291900B2 (pt)
KR (2) KR100537842B1 (pt)
CN (3) CN1132845C (pt)
AR (1) AR016821A1 (pt)
AT (2) ATE217012T1 (pt)
AU (1) AU744824B2 (pt)
BR (2) BRPI9816233B8 (pt)
CA (1) CA2245151C (pt)
CZ (1) CZ295679B6 (pt)
DE (3) DE19735711C2 (pt)
DK (2) DK0980874T3 (pt)
ES (2) ES2176870T3 (pt)
HU (2) HU228203B1 (pt)
ID (1) ID20717A (pt)
PL (1) PL191901B1 (pt)
PT (2) PT906918E (pt)
RU (2) RU2205836C2 (pt)
TR (1) TR199801587A3 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
JP2003530316A (ja) * 1999-12-22 2003-10-14 ノボ ノルディスク アクティーゼルスカブ スクランブルした一本鎖ポリペプチドの抽出的再生法
EP1303532A2 (en) * 2000-07-12 2003-04-23 Eli Lilly And Company Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
US20080032343A1 (en) 2005-12-22 2008-02-07 Genentech, Inc. Recombinant Production of Heparin Binding Proteins
SG162834A1 (en) 2006-07-14 2010-07-29 Genentech Inc Refolding of recombinant proteins
AU2008272762B2 (en) * 2007-07-03 2014-06-19 Amgen Inc. Measurement of protein using inclusion body dry weight
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
AU2009203809B2 (en) 2008-01-09 2013-07-25 Sanofi-Aventis Deutschland Gmbh Novel insulin derivatives having an extremely delayed time-action profile
US9296806B2 (en) * 2008-04-30 2016-03-29 Wockhardt Limited Processes for refolding of insulin
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
DK2498802T3 (en) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
US10421795B2 (en) 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
SG10201907106VA (en) * 2013-02-26 2019-09-27 Hanmi Pharmaceutical Co Ltd Novel insulin analog and use thereof
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
WO2015138548A1 (en) 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
EP3463413A4 (en) 2016-05-25 2020-03-04 Merck Sharp & Dohme Corp. INSULIN RECEPTOR PART AGONISTS
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用
JP7749397B2 (ja) * 2021-09-30 2025-10-06 キヤノン株式会社 超音波ファントム及び超音波ファントムの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
RU2045535C1 (ru) * 1991-06-18 1995-10-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ получения проинсулина человека
SG46612A1 (en) * 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
RU2081122C1 (ru) * 1994-06-16 1997-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ выделения и очистки инсулина или его биотехнологических предшественников
ATE350053T1 (de) * 1994-12-29 2007-01-15 Ferring Int Ct Sa Herstellung von humaninsulin
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
CZ295679B6 (cs) 2005-09-14
US6380355B1 (en) 2002-04-30
ATE217012T1 (de) 2002-05-15
ES2176870T3 (es) 2002-12-01
EP0980874A1 (de) 2000-02-23
EP0906918B1 (de) 2002-05-15
CA2245151C (en) 2009-10-06
KR20050067371A (ko) 2005-07-01
HU228203B1 (en) 2013-01-28
ES2177178T3 (es) 2002-12-01
CN1483831A (zh) 2004-03-24
HU0600287D0 (en) 2006-05-29
CN101186940A (zh) 2008-05-28
EP0906918A3 (de) 1999-08-11
US6727346B2 (en) 2004-04-27
HK1061870A1 (en) 2004-10-08
PL328108A1 (en) 1999-03-01
HK1018464A1 (en) 1999-12-24
RU2302882C2 (ru) 2007-07-20
DE19735711C2 (de) 2001-04-26
KR100537842B1 (ko) 2006-03-23
TR199801587A2 (xx) 1999-03-22
KR19990023651A (ko) 1999-03-25
ATE217636T1 (de) 2002-06-15
KR100574580B1 (ko) 2006-04-28
RU2205836C2 (ru) 2003-06-10
DE19735711A1 (de) 1999-02-25
HUP9801886A3 (en) 1999-06-28
HUP9801886A2 (hu) 1999-01-28
ID20717A (id) 1999-02-18
US5986048A (en) 1999-11-16
TR199801587A3 (tr) 1999-03-22
HK1119449A1 (en) 2009-03-06
CN1483831B (zh) 2012-06-13
CN101186940B (zh) 2012-02-08
DE59804121D1 (de) 2002-06-20
EP0980874B1 (de) 2002-05-02
JP4291900B2 (ja) 2009-07-08
US20020156234A1 (en) 2002-10-24
PT906918E (pt) 2002-10-31
AU8076398A (en) 1999-02-25
CN1132845C (zh) 2003-12-31
PL191901B1 (pl) 2006-07-31
CN1209437A (zh) 1999-03-03
DE59803985D1 (de) 2002-06-06
PT980874E (pt) 2002-10-31
EP0906918A2 (de) 1999-04-07
DK0980874T3 (da) 2002-08-19
BRPI9816233B1 (pt) 2016-09-27
BR9803755A (pt) 2000-03-28
DK0906918T3 (da) 2002-09-09
CZ259898A3 (cs) 1999-03-17
JPH11130798A (ja) 1999-05-18
AR016821A1 (es) 2001-08-01
AU744824B2 (en) 2002-03-07
CA2245151A1 (en) 1999-02-18
HU9801886D0 (en) 1998-10-28
HU228161B1 (en) 2013-01-28

Similar Documents

Publication Publication Date Title
BR9803755A (pt) Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.
BR9607061A (pt) Processo para redução de crescimento de pelos em mamíferos uso de um composto de catequina processo para produção de uma composição para a redução de crescimento de pelos em mamíferos e composição quando usada para inibir o crescimento de pelos em mamíferos
BR9910928A (pt) Composto, processo para a prepará-lo, uso do mesmo, formulação, e, processo para a profilaxia e/ou tratamento de condições clinicas associadas com resistência a insulina
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR9814300A (pt) Método de preparação de óxidos de tetraidrobenzotiepina enanciomericamente enriquecidos
BR9004523A (pt) Processo para a preparacao de um molho de soja
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR9609780A (pt) Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
BR9506473A (pt) Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas
BR9505107A (pt) Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso
BR9903984B1 (pt) processo para a produção de uma composição aquosa que contém um peptìdeo farmaceuticamente efetivo.
BR9605354A (pt) Composto composição farmacêutica processo para a produção do composto e uso
BR8905837A (pt) Composto,processo para sua preparacao e composicao fotocuravel
BR0008753B1 (pt) Composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida
PT91046A (pt) Processo para a preparacao de derivados alquilaminocarbonil-aminodiol de amino--acidos, uteis como agentes anti-hipertensivos
BR0215027A (pt) Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
BR9607346A (pt) Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos
PT839138E (pt) Processo para a preparacao de 3-hidroxipirazois substituidos em n
BR9400233A (pt) Derivados de 4-benzoilisoxazol, processo para suas preparações, composições herbicidas e método de controle herbicida
BR9507381A (pt) Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 37, 6O, 8O, 13 DA LPI9279/06

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/09/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/08/1998 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 17/08/2018